Cardiometabolic Disorders News

Adults with a higher cardiometabolic disease staging score who also experience social determinants of health have increased risks for severe COVID-19 outcomes, according to study findings published in Obesity.

The prevalence of optimal cardiometabolic health among U.S. adults declined in the past 2 decades, with disparity gaps widening based on age, sex, education and race, researchers reported.

PHILADELPHIA — In this Healio video exclusive, Seth S. Martin, MD, MHS, FACC, FAHA, FASPC, discussed the Heart in Diabetes CME conference presentation, “Digital Health Technology and Mobile Devices in Diabetes and Heart Disease.”

Heavy metals, pesticides and microplastics in the soil and water are not only environmental and ecological hazards, but they also warrant concerns from the cardiology and heart health communities.

PHILADELPHIA — For adults with type 2 diabetes and chronic kidney disease, a novel nonsteroidal mineralocorticoid receptor antagonist can play a key role in reducing risk for serious cardiorenal outcomes, according to a speaker.

PHILADELPHIA — In this Healio video exclusive, Gina Lundberg, MD, FACC, provides an overview of the Heart in Diabetes CME conference presentation, titled “CVD in Women, Ischemia Diagnosis and Menopause Hormone Therapy.”

Young adults with childhood-onset type 1 diabetes have a higher risk for heart failure than those without diabetes, and the risk for heart failure increases for those with microvascular disease, according to study data.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, discussed the recently published multidisciplinary guidelines for diabetes and cardio-renal-metabolic diseases.

Black adults with type 2 diabetes have a higher risk for developing chronic kidney disease and heart failure than white adults, and the time from diabetes diagnosis to CKD or heart failure was 12 years or less in all age groups.

PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, discussed her presentation on sex-based disparities in diabetes and their impact on atherosclerotic CVD and HF.